Challenging epilepsy in sub-Saharan Africa
Epilepsy is one of the most common serious neurological conditions and is particularly widespread in sub-Saharan Africa. This high incidence is, in at least a quarter of cases, because of preventable factors, yet many people who may have had seizures are not diagnosed and even fewer receive appropriate treatments. These factors are compounded by enduring social stigma that can make it hard for Africans with epilepsy to obtain employment, form relationships or feel valued.
From 2019 to 2024, the EPInA team will work in Accra, Nairobi, Kilifi, and Mahenge to improve all aspects of the treatment pathway: prevention, diagnosis, treatment and awareness.
WATCH OUR VIDEOS
This research was commissioned by the National Institute for Health Research using Official Development Assistance (ODA) funding. The views expressed in this website are those of the authors and not necessarily those of the NHS, the National Institute of Health Research or the Department of Health and Social Care.